Agenda

The Subcommittee held two days of hearings to examine the extent to which consumers can purchase pharmaceuticals over the Internet without a medical prescription, the importation of pharmaceuticals into the United States, and whether the pharmaceuticals from foreign sources are counterfeit, expired, unsafe, or illegitimate. This first hearing, held on June 17th examined the extent to which U.S. consumers can purchase dangerous and often addictive controlled substances from Internet pharmacy websites and the procedures utilized by the Food and Drug Administration, the Drug Enforcement Administration, the Bureau of Customs and Border Protection, and private stakeholders to address these drug safety issues.  The second hearing on this issue was held on July 22nd. 

This webcast is an audio only stream.

Witnesses

Panel 1

• Dr.  Marcia Crosse

  Director, Public Health and Military Health Care Issues

  U. S. Government Accountability Office
  Download Testimony (853k)
  
• Mr.  Robert J. Cramer

  Managing Director, Office of Special Investigations

  General Accounting Office

  Washington, DC
  Download Testimony (83k)
  

Panel 2

• The Honorable  Rudolph W. Giuliani

  Chairman and CEO

  Giuliani Partners, LLC
  Download Testimony (116k)
  
• Dr.  Marvin D. Shepherd

  Director, Center for Pharmacoeconomic Studies

  College of Pharmacy, University of Texas at Austin

  Austin, Texas
  Download Testimony (1939k)
  

Panel 3

• Ms.  Francine Haight

  Lost Son to Illegal Prescription Drugs Purchased

  Through Domestic Internet Companies

  Orange County, California
  Download Testimony (53.2 KB)
  
• Ms.  Elizabeth Carr

  Lost Husband to Illegal Prescription Drugs Purchased

  Through International Internet Companies

  Sacramento, California
  Download Testimony (41 KB)